Authors: Dear, AE Medcalf, RL

Citation: Ae. Dear et Rl. Medcalf, The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity, BBA-GENE ST, 1492(1), 2000, pp. 15-22